StonvexLoading…
StonvexStonvexStonvexCore line items from PSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.82B | $4.70B | $4.52B | $4.18B |
Operating Income | $1.79B | $2.09B | $2.17B | $4.38B |
Net Income | $1.78B | $2.07B | $2.15B | $4.35B |
EPS (Diluted) | $9.01 | $10.64 | $11.06 | $23.50 |
Total Assets | $20.21B | $19.75B | $19.81B | $17.55B |
Total Liabilities | $10.87B | $9.94B | $9.70B | $7.39B |
Cash & Equivalents | $318.10M | $447.42M | $370.00M | $775.25M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 175.90M | 176.04M | 175.67M | 175.27M |